Abdominal Lymphadenopathy

What is it?

Lymph nodes are small, bean-shaped organs distributed throughout the body along the lymphatic vessels. Lymphatic fluid drains from tissues into these vessels and passes through nodes on its way back to the bloodstream. Within each node, immune cells sample that fluid for bacteria, viruses, abnormal cells, and other material. When something is detected, the immune cells within the node multiply rapidly, and the node enlarges. Enlargement is therefore a normal immune response, not a disease in itself.

The abdomen contains a large number of lymph nodes organized into recognizable groups. Mesenteric nodes sit within the fatty tissue that suspends the small bowel. Retroperitoneal nodes lie behind the abdominal cavity, alongside the aorta and inferior vena cava, and are described as para-aortic, aortocaval, or retrocaval depending on their exact position. Porta hepatis nodes surround the entrance to the liver. Celiac, peripancreatic, and mesenteric root nodes drain the upper gastrointestinal tract. Iliac and obturator nodes lie in the pelvis and drain the pelvic organs and lower limbs. Each group drains specific territory, which means the location of enlarged nodes is itself a clue to where the causative process lies.

The critical concept is that abdominal lymphadenopathy is a sign, not a diagnosis. It indicates that something has activated the immune system in the territory those nodes drain, and the entire evaluation is directed at determining what.

Radiologists apply size thresholds to decide whether a node is enlarged, and these vary by location because normal size differs between groups. A commonly used general threshold is a short-axis diameter greater than 1 cm, though it is lower for some sites—retrocrural nodes, for instance—and higher for others. Short-axis measurement is used rather than long-axis because it is more reliable and less influenced by the plane of imaging.

Size alone, however, is an imperfect indicator, and this is worth understanding because it explains why reports often sound uncertain. Nodes enlarged by reactive inflammation frequently exceed size thresholds while being entirely benign, and normal-sized nodes can harbor microscopic tumor deposits. Radiologists therefore assess additional features: shape, since benign nodes tend to remain oval or bean-shaped while involved nodes often become rounded; the fatty hilum, the fat-containing centre of a normal node, whose preservation favors a benign process and whose loss is more concerning; clustering and confluence, where multiple nodes merge into a mass; central necrosis or low-density centres, which suggest tuberculosis, certain infections, or necrotic metastases; calcification, which may indicate prior granulomatous infection or treated disease; and whether the nodes surround and displace or encase adjacent vessels.

Distribution provides further information. Localized enlargement confined to one nodal group suggests a process in the territory that group drains. Widespread or generalized lymphadenopathy involving multiple abdominal groups, particularly with nodes elsewhere in the body, raises the likelihood of a systemic process such as lymphoma, disseminated infection, or a systemic inflammatory condition.

The causes fall into several broad categories.

Infectious causes are common and often self-limiting. Mesenteric adenitis, in which mesenteric nodes enlarge in response to a viral or bacterial gastrointestinal infection, is a frequent cause of abdominal pain in children and young adults and is a classic mimic of appendicitis—the pain is often right-sided and the two can be difficult to distinguish clinically, which is one of the more common reasons for imaging in this age group. Yersinia, Campylobacter, and Salmonella are recognized bacterial causes. Viral infections including Epstein-Barr virus, cytomegalovirus, and HIV can produce generalized lymphadenopathy. Tuberculosis is a major cause worldwide and produces a characteristic pattern of nodes with low-density or necrotic centres, often with rim enhancement; abdominal tuberculosis can occur without lung involvement. Other infections including atypical mycobacteria, histoplasmosis, brucellosis, and Whipple disease are less common but recognized.

Inflammatory and immune-mediated causes include Crohn’s disease and ulcerative colitis, which commonly produce reactive mesenteric nodes near affected bowel; celiac disease, which is associated with mesenteric lymphadenopathy and where the finding occasionally prompts the diagnosis; sarcoidosis, which can involve abdominal nodes with or without the more typical chest involvement; systemic lupus erythematosus and other connective tissue diseases; IgG4-related disease; and reactive nodes adjacent to any local inflammatory process such as diverticulitis, appendicitis, pancreatitis, or cholecystitis.

Malignant causes are the concern that drives most evaluations. Lymphoma—both Hodgkin and, more often in the abdomen, non-Hodgkin—characteristically produces bulky, often confluent nodal masses that can encase vessels without narrowing them, a pattern radiologists recognize. Metastatic spread from solid tumors follows predictable drainage pathways: gastrointestinal cancers to mesenteric, celiac, and para-aortic nodes; pancreatic cancer to peripancreatic and para-aortic nodes; testicular cancer characteristically to retroperitoneal para-aortic nodes; gynecologic and prostate cancers to pelvic and para-aortic nodes; and melanoma and breast cancer to nodes anywhere. Leukemias can also produce nodal enlargement.

Several other causes deserve mention. Castleman disease is an uncommon lymphoproliferative disorder producing localized or multicentric lymphadenopathy. Medications, including phenytoin and some others, can cause reactive lymphadenopathy. Amyloidosis and storage disorders occasionally involve nodes. Prior surgery or intervention can produce reactive nodes in the drainage territory.

Symptoms are frequently absent, and the finding is often incidental. Where symptoms occur, they usually reflect the underlying process. Mesenteric adenitis produces abdominal pain, often with fever and preceding or accompanying gastrointestinal or upper respiratory symptoms. Inflammatory bowel disease produces its own characteristic symptoms. Bulky nodal masses can cause abdominal fullness, early satiety, back pain from pressure on retroperitoneal structures, leg swelling from lymphatic or venous compression, hydronephrosis from ureteral compression, or jaundice from biliary compression.

The systemic symptoms known as B symptoms warrant particular attention because they meaningfully change the assessment: unexplained fever, drenching night sweats requiring a change of bedding, and unintentional weight loss exceeding roughly 10 percent of body weight over six months. These are associated with lymphoma and other systemic disease and prompt more urgent evaluation. Unexplained fatigue, itching without a rash, and loss of appetite are also relevant.

Evaluation begins with context. The single most important input is often not the imaging appearance but the clinical picture: the patient’s age, symptoms, infection exposure, travel history, immune status, medication list, and above all whether there is a known or suspected malignancy.

CT of the abdomen and pelvis with intravenous contrast is the primary imaging test. It maps the location, size, number, and morphology of enlarged nodes, and equally importantly surveys the abdomen for a cause—a bowel tumor, an area of inflammation, an enlarged spleen, an inflamed appendix, or a pancreatic mass.

Ultrasound is useful in children and for assessing mesenteric nodes without radiation. It shows node size and shape and can assess vascularity with Doppler, where a preserved central hilar flow pattern favors a reactive process.

MRI provides superior soft tissue contrast and is used particularly for pelvic nodal assessment, in younger patients, and where repeated imaging is anticipated.

PET-CT measures metabolic activity and is central to lymphoma staging and response assessment and to nodal staging in many solid tumors. It is important to understand that increased activity is not specific to cancer—infection, inflammation, and granulomatous disease can all be metabolically active—so PET findings are interpreted alongside everything else.

Blood tests help narrow the differential and typically include a complete blood count with differential, inflammatory markers, LDH, liver and kidney function, and depending on suspicion, HIV testing, EBV and CMV serology, tuberculosis testing, celiac serology, and autoimmune panels.

Biopsy provides the definitive answer when malignancy or granulomatous disease is suspected and imaging cannot resolve the question. Image-guided core needle biopsy is often the first approach and is adequate in many situations. For suspected lymphoma, however, excisional biopsy of an entire node is frequently preferred where accessible, because accurate subtyping depends on assessing the node’s architecture, which a needle core may not fully capture. Endoscopic ultrasound-guided sampling is useful for nodes adjacent to the stomach, duodenum, or pancreas. Fine needle aspiration alone is generally insufficient for lymphoma diagnosis.

The overall approach depends heavily on the situation. Small, isolated, morphologically normal nodes found incidentally in an otherwise well patient usually require nothing further. Nodes in a patient with a known cancer are assessed against that cancer’s expected drainage pattern and staging criteria. Widespread lymphadenopathy with B symptoms in an adult prompts prompt and structured evaluation toward a tissue diagnosis. Right-sided mesenteric nodes with acute pain in a young patient are approached quite differently, with appendicitis the primary consideration.